Two new investment opportunities have recently emerged in the market.
The Axis Momentum Fund is an open-ended equity scheme that focuses on momentum investment strategy. It aims to achieve long-term capital appreciation by investing in equity and equity-related securities that exhibit strong price momentum. The fund follows a structured and model-driven investment approach, identifying high-momentum stocks across various sectors. The management team emphasizes diversification across sectors to mitigate risks and optimize performance. Investors can participate in this fund with a minimum investment of Rs 100.
The PGIM India Healthcare Fund is designed to capitalize on the growth potential of the healthcare sector. It aims to allocate a minimum of 80% of its assets to pharmaceutical and healthcare companies. The remaining 20% is invested in other equities, debt instruments, money market instruments, REITs, InvITs, and foreign securities. The fund's strategy aligns with the anticipated growth of India's healthcare sector, driven by increasing income levels, a shift towards preventive healthcare, and rising government expenditure. The fund tracks the BSE Healthcare TRI and provides exposure to various sectors within the healthcare industry.
Investors should be aware of the unique risks associated with sector-specific funds like the PGIM India Healthcare Fund. Factors such as regulatory changes, fluctuating demand, and competition from global markets can significantly impact performance. Therefore, investors are encouraged to conduct thorough research and consider their risk tolerance before investing in these funds.
Both the Axis Momentum Fund and PGIM India Healthcare Fund offer compelling investment opportunities for diversification and capitalizing on specific market trends. These funds cater to a range of investor preferences, from those seeking momentum-driven growth to those looking to invest in the expanding healthcare sector.